Multistate Infestation with the Exotic Disease-Vector Tick Haemaphysalis longicornis - United States, August 2017-September 2018
- PMID: 30496158
- PMCID: PMC6276380
- DOI: 10.15585/mmwr.mm6747a3
Multistate Infestation with the Exotic Disease-Vector Tick Haemaphysalis longicornis - United States, August 2017-September 2018
Abstract
Haemaphysalis longicornis is a tick indigenous to eastern Asia and an important vector of human and animal disease agents, resulting in such outcomes as human hemorrhagic fever and reduction of production in dairy cattle by 25%. H. longicornis was discovered on a sheep in New Jersey in August 2017 (1). This was the first detection in the United States outside of quarantine. In the spring of 2018, the tick was again detected at the index site, and later, in other counties in New Jersey, in seven other states in the eastern United States, and in Arkansas. The hosts included six species of domestic animals, six species of wildlife, and humans. To forestall adverse consequences in humans, pets, livestock, and wildlife, several critical actions are indicated, including expanded surveillance to determine the evolving distribution of H. longicornis, detection of pathogens that H. longicornis currently harbors, determination of the capacity of H. longicornis to serve as a vector for a range of potential pathogens, and evaluation of effective agents and methods for the control of H. longicornis.
Conflict of interest statement
All authors have completed and submitted the ICMJE form for disclosure of potential conflicts of interest. Susan E. Little reports grants, personal fees, and nonfinancial support from several veterinary pharmaceutical and diagnostic companies, outside the submitted work. Mark G. Ruder reports grants from U.S. Department of Agriculture during the conduct of the study and grants from U.S. Department of Agriculture, outside the submitted work. Gary P. Wormser reports unpaid board membership in the American Lyme Disease Foundation; fees for expert medical/legal testimony regarding Lyme disease and babesiosis; grants to New York Medical College from Immunetics, Inc., Quidel Corporation, and Rarecyte, Inc. for diagnostic tests for Lyme disease and babesiosis, Tufts University for xenodiagnoses to assess persistence of Borrelia, and Institute for Systems Biology for exploration of biomarkers for Lyme disease outcomes; U.S. Patent Application, “High Sensitivity Method for Early Lyme Disease Detection” (Application No. 15/046,204); and U.S. Provisional Patent Application, “Use of Metabolic Biosignatures for Differentiation of Early Lyme Disease from Southern Tick-Associated Rash Illness (STARI)” (Application No. 62/277,252); and stock/stock options in Abbott/AbbVie. No other potential conflicts of interest were disclosed.
Figures

References
MeSH terms
LinkOut - more resources
Full Text Sources